acobiom.com

Website and Business Overview

Acobiom is an innovative biotechnology company headquartered in France. Its core business focuses on biomarker discovery and innovative diagnostic product development in the field of precision medicine, and it also provides professional omics research services for clients in the life science sector. The official website fully showcases the company's technical advantages, core products, service scope and cooperation cases. Its core product, GemciTest®, is a blood diagnostic test developed specifically for pancreatic cancer. It can predict how patients will respond to gemcitabine chemotherapy, helping clinicians deliver personalized treatment.

Core Functions and Services

Acobiom's business is divided into two main segments:

1. Diagnostic Products: It has currently developed non-invasive blood diagnostic products including GemciTest® for pancreatic cancer. The test predicts chemotherapy response through RNA signature panels to support clinical personalized medication decision-making, and is already undergoing collaborative clinical validation with the Montpellier Cancer Institute in France.
2. Customized Omics Research Services: It covers the full process from experimental design, sample processing, sequencing, bioinformatics analysis to statistical reporting. It provides a wide range of technical services including RNA-Seq, whole-genome sequencing, exome sequencing, qPCR and microbiome analysis, and also supports efficacy and toxicity biomarker research for the cosmetics sector. All service processes comply with clinical research regulatory standards.

Pros, Cons and Target Users

Pros: Acobiom has over 20 years of industry experience, its technical processes are clinically validated, and the core non-invasive blood test has better accessibility than traditional tissue biopsies. Its end-to-end service also reduces coordination costs for clients.
Cons: The official website does not disclose any pricing information, all cooperation inquiries require individual consultation, and it only serves professional institutions, not general individual users.

This website is suitable for cooperation and connection with Chinese life science research teams, innovative pharmaceutical companies, and clinical research institutions. General patients cannot directly obtain services through this website.

Accessibility in China

The website does not require a proxy to access at present, it can be visited directly and normally. The official website offers English and French language versions, and does not have a Chinese interface.